Phoenix Bio

研究発表

研究発表

Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans

    Nakada, N. Kawamura, A. Kamimura, H. Sato, K. Kazuki, Y. Kakuni, M. Ohbuchi, M. Kato, K. Tateno, C. Oshimura, M. Usui, T.

    Biopharm Drug Dispos. 2015 Sep 9. doi: 10.1002/bdd.1990.

    Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver

      Kato, K. Ohbuchi, M. Hamamura, S. Ohshita, H. Kazuki, Y. Oshimura, M. Sato, K. Nakada, N. Kawamura, A. Usui, T. Kamimura, H. Tateno, C.

      Drug Metab Dispos. 2015 Aug;43(8):1208-17.

       

      Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans

        Nakada, N. Oda, K.

        Xenobiotica. 2015 Apr 14:1-9.

        Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver

          Sanoh, S. Naritomi, Y. Fujimoto, M. Sato, K. Kawamura, A. Horiguchi, A.Sugihara, K. Kotake, Y. Ohshita, H. Tateno, C. Horie, T. Kitamura, S. Ohta, S.

          Xenobiotica. 2015 Mar 3:1-10.

          Zone analysis by two-dimensional electrophoresis with accelerator mass spectrometry of in vivo protein bindings of idiosyncratic hepatotoxicants troglitazone and flutamide bioactivated in chimeric mice with humanized liver

            Yamazaki, H. Kuribayashi, S. Inoue, T. Honda,T. Tateno, C. Oofusa, K. Ninomiya, S.Ikedag , T. Izumi, T and Horie, T

            Toxicology Research

            Chimeric Mice with Hepatocyte-humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator-activated Receptor-alpha

              Tateno, C. Yamamoto, T. Utoh, R. Yamasaki, C. Ishida, Y. Myoken, Y. Oofusa, K. Okada, M. Tsutsui, N. Yoshizato, K.
              Toxicol Pathol. 2014 Aug 8. pii: 0192623314544378.

              Application of Chimeric Mice with Humanized Liver for Study of Human-Specific Drug Metabolism

                Bateman, T. Reddy, V. B. Kakuni, M. Morikawa, Y. Kumar, S.
                Drug Metab Dispos. 2014 Jun;42(6):1055-65.

                Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS

                  Ohtsuki, S. Kawakami, H. Inoue, T. Nakamura, K. Tateno, C. Katsukura, Y. Obuchi, W. Uchida, Y. Kamiie, J. Horie, T. Terasaki, T.
                  Drug Metab Dispos. 2014 Jun;42(6):1039-43.

                  Chimeric Mice with Humanized Livers: A Unique Tool for in Vivo and in Vitro Enzyme Induction Studies

                    Masakazu Kakuni, Chihiro Yamasaki, Asato Tachibana, Yasumi Yoshizane, Yuji Ishida and Chise Tateno
                    Int. J. Mol. Sci. 2014, 15, 58-74

                    In vitro and in vivo metabolism of a novel chymase inhibitor, SUN13834, and the predictability of human metabolism using mice with humanized liver

                      Igawa, Y. Fujitani, T. Shah, B. Oo, C. Kanai, Y.
                      Xenobiotica. 2014 Jan;44(2):154-63.

                      Endogenous and xenobiotic metabolite profiling of liver extracts from SCID and chimeric humanized mice following repeated oral administration of troglitazone

                        Barnes, A. J. Baker, D. R. Hobby, K. Ashton, S. Michopoulos, F. Spagou, K. Loftus, N. J. Wilson, I. D.
                        Xenobiotica. 2014 Jan; 44(2): 174-85.

                        Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.

                          Tanoue C, Sugihara K, Uramaru N, Tayama Y, Watanabe Y, Horie T, Ohta S, Kitamura S
                          Xenobiotica. 2013 Nov;43(11):956-62.

                          Investigation of Drug-drug Interactions Caused by Human Pregnane X Receptor-mediated Induction of Cytochrome P450 3A4 and 2C Subfamilies in Chimeric Mice with a Humanized Liver.

                            Hasegawa M, Tahara H, Inoue R, Kakuni M, Tateno C, Ushiki J.
                            Drug Metab Dispos. 2012 40(3)474-480

                            Prediction of In Vivo Hepatic Clearance and Half-Life of Drug Candidates in Human Using Chimeric Mice with Humanized Liver

                              Sanoh S, Horiguchi A, Sugihara K, Kotake Y, Tayama Y, Ohshita H, Tateno C, Horie T, Kitamura S, Ohta S.
                              Drug Metab Dispos. 2011 40(2)322-8

                              Prediction of Human Metabolism of FK3453 by Aldehyde Oxidase Using Chimeric Mice Transplanted with Human or Rat Hepatocytes.

                                Sanoh S, Nozaki K, Murai H, Terashita S, Teramura T, Ohta S.
                                Drug Metab Dispos. 2011 40(1)76-82

                                Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.

                                  Schulz-Utermoehl T, Sarda S, Foster JR, Jacobsen M, Kenna JG, Morikawa Y, Salmu J, Gross G, Wilson ID.
                                  Xenobiotica. 2012 Jun;42(6):503-17.

                                  Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.

                                    Sanoh S, Horiguchi A, Sugihara K, Kotake Y, Tayama Y, Uramaru N, Ohshita H, Tateno C, Horie T, Kitamura S, Ohta S.
                                    Drug Metab Dispos. 2012 Dec;40(12):2267-72.

                                    Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers

                                      Samuelsson K, Pickup K, Sarda S, Swales JG, Morikawa Y, Schulz-Utermoehl T, Hutchison M, Wilson ID.
                                      Xenobiotica. 2012 Nov;42(11):1128-37.

                                      Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton’s tyrosine kinase inhibitor.

                                        Liu L, Halladay JS, Shin Y, Wong S, Coraggio M, La H, Baumgardner M, Le H, Gopaul S, Boggs J, Kuebler P, Davis JC Jr, Liao XC, Lubach JW, Deese A, Sowell CG, Currie KS, Young WB, Khojasteh SC, Hop CE, Wong H.
                                        Drug Metab Dispos. 2011 Oct;39(10):1840-9.

                                        Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism.

                                          De Serres M, Bowers G, Boyle G, Beaumont C, Castellino S, Sigafoos J, Dave M, Roberts A, Shah V, Olson K, Patel D, Wagner D, Yeager R, Serabjit-Singh C.
                                          Xenobiotica. 2011 Jun;41(6):464-75.